Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AC Immune (ACIU) Return on Equity: 2016-2025

Historic Return on Equity for AC Immune (ACIU) over the last 10 years, with Sep 2025 value amounting to -2.20%.

  • AC Immune's Return on Equity fell 155.00% to -2.20% in Q3 2025 from the same period last year, while for Sep 2025 it was -2.20%, marking a year-over-year decrease of 155.00%. This contributed to the annual value of -0.38% for FY2024, which is 3.00% down from last year.
  • AC Immune's Return on Equity amounted to -2.20% in Q3 2025, which was down 93.98% from -1.14% recorded in Q2 2025.
  • In the past 5 years, AC Immune's Return on Equity registered a high of -0.00% during Q2 2021, and its lowest value of -168.96% during Q4 2024.
  • Moreover, its 3-year median value for Return on Equity was -0.92% (2023), whereas its average is -16.21%.
  • Its Return on Equity has fluctuated over the past 5 years, first spiked by 47bps in 2023, then plummeted by 16,858bps in 2024.
  • Quarterly analysis of 5 years shows AC Immune's Return on Equity stood at -0.00% in 2021, then plummeted by 84bps to -0.84% in 2022, then soared by 47bps to -0.37% in 2023, then slumped by 16,858bps to -168.96% in 2024, then plummeted by 155bps to -2.20% in 2025.
  • Its Return on Equity stands at -2.20% for Q3 2025, versus -1.14% for Q2 2025 and -1.14% for Q1 2025.